Wednesday, June 3, 2009

Urodynamix's financial report indicates demand for NIRS technology

This week, Urodynamix Technologies Ltd. reported exciting news: Financial results for its fiscal first quarter (ended March 31) showed a 1,269%increase from revenues in Q1 2008. The spike resulted from the first commercial sales of the company's URO NIRS 2000 in the quarter--and as of March 31, the company had an order backlog of $92,576.


This week, Urodynamix Technologies Ltd. reported exciting news: Financial results for its fiscal first quarter (ended March 31) showed a 1,269% increase from revenues in Q1 2008. The spike resulted from the first commercial sales of the company's URO NIRS 2000 in the quarter--and as of March 31, the company had an order backlog of $92,576.

Urodynamix has been busy working partnerships to get its near infrared spectroscopy products out into the world. For instance a new agreement with pharmaceuticals giant Pfizer has the partners collaborating on promotional programs to increase awareness of UroNIRS Bladder Monitor technology among urologists and medical professionals. And a product development and distribution agreement with Timm Medical Technologies aims to apply NIRS to erectile dysfunction.

No comments: